Old Web
English
Sign In
Acemap
>
Paper
>
Type 2 Biomarkers and Eosinophil Activation in Severe Asthma and the Impact of Mepolizumab
Type 2 Biomarkers and Eosinophil Activation in Severe Asthma and the Impact of Mepolizumab
2019
Peter H. Howarth
S. Quirce
Alberto Papi
Elliot Israel
Stephen Mallett
Stewart Bates
Frank C. Albers
Namhee Kwon
Keywords:
Mepolizumab
Asthma
Biomarker (medicine)
Eosinophil activation
Medicine
Immunology
severe asthma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]